Used as a key chiral intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of central nervous system agents and kinase inhibitors. Its trifluorinated aromatic structure enhances binding selectivity and metabolic stability in drug candidates. Commonly employed in asymmetric synthesis to introduce fluorinated amino acid motifs into bioactive molecules, improving their pharmacokinetic profiles. Also utilized in the preparation of peptidomimetics for research in neurodegenerative diseases and cancer therapeutics.